2004
DOI: 10.1253/circj.68.29
|View full text |Cite
|
Sign up to set email alerts
|

Effects of Anticoagulation Intensity on Hemostatic Markers in Patients With Non-Valvular Atrial Fibrillation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
48
0

Year Published

2005
2005
2018
2018

Publication Types

Select...
8
2

Relationship

3
7

Authors

Journals

citations
Cited by 44 publications
(50 citation statements)
references
References 29 publications
2
48
0
Order By: Relevance
“…22 In a previous study, the effects of the INR value on hemostatic marker levels were analyzed in Japanese patients with NVAF. 23 It was found that the reduction in D-dimer levels observed at an INR of between 1.5 and 1.99 was similar to that seen at an INR of 2.00 or higher. 23 Therefore, an INR of between 1.5 and 1.99 is also effective at preventing thrombus formation in the cardiovascular system, which suggests that lower INR values (between 1.5 and 1.99) are as effective as INR values of between 2 and 3 at preventing embolic events in patients with NVAF.…”
Section: Resultsmentioning
confidence: 67%
“…22 In a previous study, the effects of the INR value on hemostatic marker levels were analyzed in Japanese patients with NVAF. 23 It was found that the reduction in D-dimer levels observed at an INR of between 1.5 and 1.99 was similar to that seen at an INR of 2.00 or higher. 23 Therefore, an INR of between 1.5 and 1.99 is also effective at preventing thrombus formation in the cardiovascular system, which suggests that lower INR values (between 1.5 and 1.99) are as effective as INR values of between 2 and 3 at preventing embolic events in patients with NVAF.…”
Section: Resultsmentioning
confidence: 67%
“…38,39 Therefore, further investigation is necessary to clarify whether the Ddimer assay can differentiate AADa from these diseases, but we believe that by setting an appropriate cutoff value for the assay AADa can be differentiated from AMI in the emergency department before initiation of reperfusion therapy, even if the D-dimer value is not diagnostic for AADa because of its lack of specificity. 24 …”
Section: D-dimer Concentrationmentioning
confidence: 99%
“…The diagnostic criteria for these thromboembolic events have been reported previously. 7,8 The INR levels at the time of enrollment, within 6 months of the primary end point and at the time of thromboembolic events were analyzed.…”
mentioning
confidence: 99%